Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 860 participants.
Also called NCT04660240
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 860 participants
- Registry
-
NCT04660240
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Mexico
- Registry status
- Unknown status
Technical summary
Registry record NCT04660240. Randomized; single masking; primary purpose treatment. Start 2020-10-01 (actual); primary completion 2025-05-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus
- Acronym
- INC-DM
- Condition
- Diabetes Mellitus
- Condition
- Coronary Artery Disease
- Condition
- Acute Coronary Syndrome
- Intervention (Device)
- Abluminus Sirolimus Eluting Stent System (ASES)
- Intervention (Device)
- Orsiro Sirolimus Eluting Coronary Stent System (OSES)
- Lead sponsor
- Instituto Nacional de Cardiologia Ignacio Chavez
Record details
- Record id
cardio:ct-nct04660240- Content hash
3b731aa2fd6a6f91ff826e99b9b5ffa525ec1d8e5d8c41dab669a59bf9560cb7